← Scoopfeeds — Intelligent news, curated.
Rapport Therapeutics stock hits all-time high at 42.36 USD
business

Rapport Therapeutics stock hits all-time high at 42.36 USD

Investing.com · Jun 30, 2026, 3:48 PM · Also reported by 4 other sources

Rapport Therapeutics stock hits all-time high at 42.36 USD

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Sandisk Stock Gets Sky-High Price Target Amid Chip Stock Rally Yahoo Finance Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout? Yahoo Finance Is Celldex Therapeutics, Inc. (CLDX) Stock Positioned for Growth Ahead of Potential 2027 Approval? Yahoo Finance Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update?

More in business

CNBC
Major egg producers settle price inflation probe for $3.3 million
Investing.com
Europe’s STOXX 600 clocks biggest quarterly gain in over five years on AI boost
CNBC
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
Investing.com
Focus Xplore reports £640,095 loss for 2025
Investing.com
Globe Life EVP Skarjune sells $331,483 in stock
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop